Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
IPSC•Q2 net income and EPS miss estimates
Aug. 12 (Reuters) - Century Therapeutics Q2 basic EPS USD -0.17.
- Q2 operating expenses USD 36.527 million
- Q2 operating income USD -36.527 million vs. IBES estimate USD -24.5 million
